Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
2
×
national blog main
national top stories
new york blog main
2
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
2
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
arena pharmaceuticals
biotech
blueprint medicines
cardiovascular disease
colorectal cancer
companion diagnostic
dna sequencing
drugs
eisai
entrectinib
europe blog main
What
cancer
2
×
drug
fda
2
×
medicine
approved
deeper
dna
eisai
fingerprint
flags
genetic
going
higher
incidence
lorcaserin
loss
market
marketing
matter
nd
new
oks
patients
post
pulls
risks
second
study
targets
time
tissues
took
tumor's
weight
withdrawing
world
Language
unset
Current search:
fda
×
cancer
×
national
×
photo
×
" seattle blog main "
×
" new york blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues